|
Research and Clinical Trials
Vitiligo Support International does not in any way warranty, endorse or maintain any responsibility for the research or clinical studies listed here. Those participating or volunteering do so of their own accord.
A
Randomized Controlled Pilot Study to Examine the Use of Micrografting, Using a
Novel Grafting Technique, for the Repigmentation of Vitiligo
Principle
Investigator - Alexandra B. Kimball MD, MPH
Study
Location: Massachusetts General Hospital, Boston, MA
Study
Description: The Dermatology Clinical Unit for
Research Trials is recruiting subjects 18 years of age and older with vitiligo.
The purpose is to study the use of micrografting technique in patients with
vitiligo.
The study may last up to 24 weeks and
requires about 8 study visits. You will receive up to $550 for participating in
this study.
Eligibility
Criteria - Subject of 18 years of age and older has 3 comparable
vitiliginous areas of trunk or extremities (excluding hands) each measuring at
least 3cm×3cm in size, with at least 80% depigmentation, and anticipated equal
sun exposure. If you are currently taking certain medications for vitiligo, you
may not be eligible for this trial. Please consult your doctor. Other
restrictions will be explained at the screening visit.
Enrollment
Information - For further information about participating in this trial,
contact Lynne at (617) 726-5066 or email harvardskinstudies@partners.org.
Lei soffre di vitiligine?
L?Istituto Dermatologico San Gallicano (Istituti Fiosioterapici
Ospitalieri, IFO, Roma) sta conducendo unostudio clinico su un nuovo
trattamento contro la vitiligine: un farmaco sperimentale che sarà utilizzato
incombinazione con fototerapia ultravioletta B a banda stretta (NB-UVB).
Questa terapia e mirata a pazienti adulti affetti da meno di 5 anni da
vitiligine non-segmentale sul viso e il corpo.
Lo studio si compone di un periodo di trattamento di 6 mesi con
fototerapia NB-UVB 3 volte alla settimana, con o senza la somministrazione del
farmaco sperimentale. Seguirà un periodo di follow-up di 6 mesi con una visita
presso l? Istituto ogni 2 mesi.
L'intero studio durerà circa 1 anno e comprenderà fototerapia NB-UVB e
11 visite presso Istituto Dermatologico San Gallicano (IFO, Roma). La partecipazione allo studio è
gratuita e le spese di viaggio saranno interamente rimborsate. I vostri dati saranno trattati in
maniera confidenziale.
Siete interessati?
Se siete interessati, vi preghiamo di contattarci: Dr Giovanni Leone Indirizzo: Istituto Dermatologico San Gallicano / IFO Via Elio Chianesi, 53 00144 Roma, Italia
Updated 03/12/11
Take Part in International Study to Find Vitiligo Genes (Questionnaire) University of Colorado Health School of Medicine
Do you have Vitiligo, or have you had it in the past? Or, does
someone in your family have Vitiligo? If so, would you or they be
willing to take part in a major research project on Vitiligo?
We have put together an international team of
scientists to find the genes that cause Vitiligo. By studying thousands of
vitiligo patients from around the world, we have discovered at least 17 genes
that contribute to causing vitiligo. Our goal is to discover additional
vitiligo risk genes, discover the specific changes in these genes that cause
risk for vitiligo and understand how these genes act in combination to confer
risk for vitiligo and other autoimmune diseases that are often associated with
Vitiligo (including autoimmune thyroid disease, rheumatoid arthritis,
psoriasis, pernicious anemia, lupus, Addison disease, and adult-onset
insulin-dependent diabetes). Our long-term goal is to better understand the
causes of vitiligo and these related diseases, so as to develop better
treatments and even approaches to prevention of these diseases altogether.
The first step in your participating is to fill
out the questionnaire below (Microsoft Word Document) and send it to us via
email or regular mail. The email address and mailing address are contained at
the end of the questionnaire. We will then contact respondents that might be
appropriate to the study to get further information and arrange for a saliva
(spit) sample. We thank you in advance for your help, and we look forward to
hearing from you.
If you live in North America and are of
Caucasian (white), Hispanic/Latino, or African-American origin, your
participation as a research volunteer is vitally needed to help identify the
genes linked to vitiligo. Scientists with the international VitGene Consortium
project spanning 18 countries are working to understand the biology of vitiligo
in order that more effective vitiligo treatments can be designed.
Richard A. Spritz, M.D. Professor and Director Human Medical Genetics Program University of Colorado School of Medicine Anschutz Medical Campus 12800 East 19th Avenue, Room 3100 P.O. Box 6511, Mail-stop 8300 Aurora, CO 80045 USA Tel: 303-724-3107 Fax: 303-724-3100 Email: richard.spritz@ucdenver.edu
CLICK HERE TO DOWNLOAD THE QUESTIONNAIRE
Call for Patients: Vogt-Koyanagi-Harada Disease (VKH)
We are hoping to start a new genetic study specifically on Vogt-Koyanagi-Harada Disease, a rare autoimmune syndrome characterized by uveitis, meningitis, dysacusis, alopecia, poliosis, and vitiligo. If you have VKH disease, please email me as soon as possible, Thank you,
Richard A. Spritz, M.D.
Tel 303-724-3107 FAX 303-724-3100 Email richard.spritz@ucdenver.edu
Check back soon for new opportunities!
Other Research & Treatments:
|